305 related articles for article (PubMed ID: 29732486)
1. Metallothionein is elevated in liver and duodenum of Atp7b
Zhang CC; Volkmann M; Tuma S; Stremmel W; Merle U
Biometals; 2018 Aug; 31(4):617-625. PubMed ID: 29732486
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a critical role of ceruloplasmin oxidase activity in iron metabolism of Wilson disease gene knockout mice.
Merle U; Tuma S; Herrmann T; Muntean V; Volkmann M; Gehrke SG; Stremmel W
J Gastroenterol Hepatol; 2010 Jun; 25(6):1144-50. PubMed ID: 20594231
[TBL] [Abstract][Full Text] [Related]
3. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R
J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483
[TBL] [Abstract][Full Text] [Related]
4. Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models.
Mi X; Li Z; Yan J; Li Y; Zheng J; Zhuang Z; Yang W; Gong L; Shi J
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165842. PubMed ID: 32446740
[TBL] [Abstract][Full Text] [Related]
5. In
Sharma Y; Liu J; Kristian KE; Follenzi A; Gupta S
Gene Expr; 2018 Dec; 19(1):15-24. PubMed ID: 30029699
[TBL] [Abstract][Full Text] [Related]
6. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
7. Metabolic dysregulation in the
Wooton-Kee CR; Robertson M; Zhou Y; Dong B; Sun Z; Kim KH; Liu H; Xu Y; Putluri N; Saha P; Coarfa C; Moore DD; Nuotio-Antar AM
Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2076-2083. PubMed ID: 31924743
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Correction of Copper Metabolism in Wilson's Disease Mice with AAV8 Vector Delivering Truncated ATP7B.
Leng Y; Li P; Zhou L; Xiao L; Liu Y; Zheng Z; Qin F; Hao Q; Xu H; Yao S; Dong B
Hum Gene Ther; 2019 Dec; 30(12):1494-1504. PubMed ID: 31668086
[TBL] [Abstract][Full Text] [Related]
9. Intestinal expression of metal transporters in Wilson's disease.
Przybyłkowski A; Gromadzka G; Wawer A; Grygorowicz T; Cybulska A; Członkowska A
Biometals; 2013 Dec; 26(6):925-34. PubMed ID: 23963605
[TBL] [Abstract][Full Text] [Related]
10. Long-term metabolic correction of Wilson's disease in a murine model by gene therapy.
Murillo O; Luqui DM; Gazquez C; Martinez-Espartosa D; Navarro-Blasco I; Monreal JI; Guembe L; Moreno-Cermeño A; Corrales FJ; Prieto J; Hernandez-Alcoceba R; Gonzalez-Aseguinolaza G
J Hepatol; 2016 Feb; 64(2):419-426. PubMed ID: 26409215
[TBL] [Abstract][Full Text] [Related]
11. Visualization of the therapeutic efficacy of a gene correction approach in Wilson's disease by laser-ablation inductively coupled mass spectrometry.
Moreno D; Murillo O; Gazquez C; Hernandez-Alcoceba R; Uerlings R; Gonzalez-Aseguinolaza G; Weiskirchen R
J Hepatol; 2018 May; 68(5):1088-1090. PubMed ID: 29317295
[No Abstract] [Full Text] [Related]
12. Functional iron deficiency in toxic milk mutant mice (tx-J) despite high hepatic ferroportin: a critical role of decreased GPI-ceruloplasmin expression in liver macrophages.
Jończy A; Lipiński P; Ogórek M; Starzyński RR; Krzysztofik D; Bednarz A; Krzeptowski W; Szudzik M; Haberkiewicz O; Miłoń A; Grzmil P; Lenartowicz M
Metallomics; 2019 Jun; 11(6):1079-1092. PubMed ID: 31011744
[TBL] [Abstract][Full Text] [Related]
13. Altered zinc balance in the Atp7b
Meacham KA; Cortés MP; Wiggins EM; Maass A; Latorre M; Ralle M; Burkhead JL
Metallomics; 2018 Nov; 10(11):1595-1606. PubMed ID: 30277246
[TBL] [Abstract][Full Text] [Related]
14. Modifying factors and phenotypic diversity in Wilson's disease.
Lutsenko S
Ann N Y Acad Sci; 2014 May; 1315():56-63. PubMed ID: 24702697
[TBL] [Abstract][Full Text] [Related]
15. Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration).
Nartey NO; Frei JV; Cherian MG
Lab Invest; 1987 Oct; 57(4):397-401. PubMed ID: 3312808
[TBL] [Abstract][Full Text] [Related]
16. Urinary copper elevation in a mouse model of Wilson's disease is a regulated process to specifically decrease the hepatic copper load.
Gray LW; Peng F; Molloy SA; Pendyala VS; Muchenditsi A; Muzik O; Lee J; Kaplan JH; Lutsenko S
PLoS One; 2012; 7(6):e38327. PubMed ID: 22802922
[TBL] [Abstract][Full Text] [Related]
17. Fragmentation of mitochondrial cardiolipin by copper ions in the Atp7b-/- mouse model of Wilson's disease.
Yurkova IL; Arnhold J; Fitzl G; Huster D
Chem Phys Lipids; 2011 Jul; 164(5):393-400. PubMed ID: 21645498
[TBL] [Abstract][Full Text] [Related]
18. Structural and metabolic changes in Atp7b-/- mouse liver and potential for new interventions in Wilson's disease.
Huster D
Ann N Y Acad Sci; 2014 May; 1315():37-44. PubMed ID: 24697742
[TBL] [Abstract][Full Text] [Related]
19. Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease.
Roybal JL; Endo M; Radu A; Gray L; Todorow CA; Zoltick PW; Lutsenko S; Flake AW
Gene Ther; 2012 Nov; 19(11):1085-94. PubMed ID: 22158007
[TBL] [Abstract][Full Text] [Related]
20. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.
Cai H; Cheng X; Wang XP
Hepatology; 2022 Oct; 76(4):1046-1057. PubMed ID: 35340061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
